Published in Plast Reconstr Surg on June 01, 2008
Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction. Clin Interv Aging (2010) 0.86
Botulinum toxin type A treatment to the upper face: retrospective analysis of daily practice. Clin Cosmet Investig Dermatol (2012) 0.85
Safety and Patient Satisfaction of AbobotulinumtoxinA for Aesthetic Use: A Systematic Review. Aesthet Surg J (2017) 0.81
Duration of action of abobotulinumtoxina and onabotulinumtoxina: a randomized, double-blind study using a contralateral frontalis model. J Clin Aesthet Dermatol (2011) 0.81
Botulinum toxin type-A in the treatment of glabellar lines. Clin Cosmet Investig Dermatol (2009) 0.75
Soft-tissue filler complications: the important role of biofilms. Plast Reconstr Surg (2010) 2.18
Current status of surgery in dermatology. J Am Acad Dermatol (2013) 1.98
Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne. J Am Acad Dermatol (2004) 1.53
Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol (2004) 1.51
Delayed-onset nodules secondary to a smooth cohesive 20 mg/mL hyaluronic acid filler: cause and management. Dermatol Surg (2015) 1.47
Seeking simplicity: golf tips and blepharoplasty. Plast Reconstr Surg (2003) 1.40
A Pilot Study on the Treatment of Posterior Cheek Enlargement in HIV+ Patients With Botulinum Toxin A. Dermatol Surg (2015) 1.39
A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol (2002) 1.39
Management of Patient Experience With ATX-101 (Deoxycholic Acid Injection) for Reduction of Submental Fat. Dermatol Surg (2016) 1.38
Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines. Dermatol Surg (2010) 1.33
Blindness caused by cosmetic filler injection: a review of cause and therapy. Plast Reconstr Surg (2014) 1.23
Treatment of injectable soft tissue filler complications. Dermatol Surg (2009) 1.17
Meta-analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®) across multiple indications. Mov Disord (2010) 1.15
Consensus recommendations on the use of botulinum toxin type a in facial aesthetics. Plast Reconstr Surg (2004) 1.14
A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose. Dermatol Surg (2007) 1.13
Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial. Arch Dermatol (2002) 1.07
Role of new fillers in facial rejuvenation: a cautious outlook. Plast Reconstr Surg (2003) 1.05
The use of photodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol (2006) 1.03
Current concepts in aesthetic upper blepharoplasty. Plast Reconstr Surg (2004) 1.02
Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol (2003) 1.01
HIV-associated facial lipoatrophy. Dermatol Surg (2002) 1.00
Validated assessment scales for the lower face. Dermatol Surg (2012) 0.97
Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies. Int J Dermatol (2009) 0.96
Validated assessment scales for the upper face. Dermatol Surg (2012) 0.95
Anatomic guidelines for augmentation of the cheek and infraorbital hollow. Dermatol Surg (2012) 0.94
Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept. J Am Acad Dermatol (2006) 0.94
Cosmetic medicine: facial resurfacing and injectables. Plast Reconstr Surg (2012) 0.93
Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study. J Am Acad Dermatol (2011) 0.93
Validated composite assessment scales for the global face. Dermatol Surg (2012) 0.93
Facial Soft-Tissue Fillers conference: Assessing the State of the Science. J Am Acad Dermatol (2011) 0.92
Botulinum toxin type A treatment of multiple upper facial sites: patient-reported outcomes. Dermatol Surg (2007) 0.92
Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations. Plast Reconstr Surg (2016) 0.90
Aesthetic botulinum A toxin in the mid and lower face and neck. Dermatol Surg (2003) 0.90
3D photography and lip filler: a novel assay. J Cosmet Laser Ther (2007) 0.89
Efficacy and safety of onabotulinumtoxinA for treating crow's feet lines alone or in combination with glabellar lines: a multicenter, randomized, controlled trial. Dermatol Surg (2015) 0.89
Cryolipolysis and skin tightening. Dermatol Surg (2014) 0.89
Botulinum toxin type A for facial aesthetic enhancement: role in facial shaping. Plast Reconstr Surg (2003) 0.88
Cohesive Polydensified Matrix Hyaluronic Acid for Fine Lines. Plast Reconstr Surg (2015) 0.88
A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. J Am Acad Dermatol (2010) 0.88
Recommendations and current practices for the reconstitution and storage of botulinum toxin type A. J Am Acad Dermatol (2011) 0.87
The natural history of polymethylmethacrylate microspheres granulomas. Dermatol Surg (2007) 0.87
Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks. J Am Acad Dermatol (2003) 0.86
Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction. Clin Interv Aging (2010) 0.86
Botox: beyond wrinkles. Clin Dermatol (2004) 0.86
Facial aesthetics: achieving the natural, relaxed look. J Cosmet Laser Ther (2007) 0.84
Botulinum toxin A: its expanding role in dermatology and esthetics. Am J Clin Dermatol (2003) 0.84
Validated assessment scales for the mid face. Dermatol Surg (2012) 0.84
Deep resting glabellar rhytides respond to BTX-A and Hylan B. Dermatol Surg (2003) 0.84
Current systemic therapies for psoriasis: where are we now? J Am Acad Dermatol (2003) 0.84
The horizontal dynamic of the medial and lateral canthus. Ophthal Plast Reconstr Surg (2003) 0.84
Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis. Clin Dermatol (2004) 0.84
Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis: efficacy and duration with repeated treatments. Dermatol Surg (2003) 0.83
Review of key Belotero Balance safety and efficacy trials. Plast Reconstr Surg (2013) 0.83
Consensus panel's assessment and recommendations on the use of 3 botulinum toxin type A products in facial aesthetics. Aesthet Surg J (2013) 0.83
The effect of full-face broadband light treatments alone and in combination with bilateral crow's feet Botulinum toxin type A chemodenervation. Dermatol Surg (2004) 0.82
Surgical pearl: the use of the Ultra-Fine II short needle 0.3-cc insulin syringe for botulinum toxin injections. J Am Acad Dermatol (2002) 0.82
Global Aesthetics Consensus: Botulinum Toxin Type A-Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use, Including Updates on Complications. Plast Reconstr Surg (2016) 0.82
Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes. Dermatol Surg (2010) 0.81
Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept. J Am Acad Dermatol (2006) 0.81
Commentary: electromagnetic radiation and wound healing. Dermatol Surg (2012) 0.81
Botulinum toxin A in the mid and lower face and neck. Dermatol Clin (2004) 0.80
Handling botulinum toxins: an updated literature review. Dermatol Surg (2011) 0.80
Changing role of hyaluronidase in plastic surgery. Plast Reconstr Surg (2014) 0.80
Facial sculpting and tissue augmentation. Dermatol Surg (2005) 0.80
Secondary upper eyelid blepharoplasty. Aesthet Surg J (2009) 0.80
The skin in pregnancy. J Cutan Med Surg (2002) 0.80
The cosmetic use of botulinum toxin. Plast Reconstr Surg (2003) 0.80
Skin extracellular matrix stimulation following injection of a hyaluronic acid-based dermal filler in a rat model. Plast Reconstr Surg (2014) 0.80
Botulinum toxin type A gives adjunctive benefit to periorbital laser resurfacing. J Cosmet Laser Ther (2004) 0.79
The treatment of psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy, and safety. Dermatol Clin (2004) 0.79
Complications of botulinum toxin type A. Facial Plast Surg Clin North Am (2007) 0.79
Etanercept therapy allows the tapering of methotrexate and sustained clinical responses in patients with moderate to severe psoriasis. Int J Dermatol (2008) 0.79
Preventing and managing dry eyes after periorbital surgery: a retrospective review. Plast Reconstr Surg (2009) 0.78
Infraorbital hollow treatment by dermal fillers. Dermatol Surg (2007) 0.78
Clinical Experience With 11,460 mL of a 20-mg/mL, Smooth, Highly Cohesive, Viscous Hyaluronic Acid Filler. Dermatol Surg (2015) 0.78
Upper Face: Clinical Anatomy and Regional Approaches with Injectable Fillers. Plast Reconstr Surg (2015) 0.78
Highly purified 1000-cSt silicone oil for treatment of human immunodeficiency virus-associated facial lipoatrophy: an open pilot trial. Dermatol Surg (2004) 0.78
Safety and efficacy of nonanimal stabilized hyaluronic acid for improvement of mouth corners. Dermatol Surg (2005) 0.78
A review of AbobotulinumtoxinA (Dysport). Aesthet Surg J (2013) 0.78
Three-Dimensional Forehead Reflation. Dermatol Surg (2015) 0.78
A comparison of two botulinum type a toxin preparations for the treatment of glabellar lines: double-blind, randomized, pilot study. Dermatol Surg (2005) 0.77
Botulinum toxin in facial rejuvenation: an update. Dermatol Clin (2009) 0.77
Volumizing with a 20-mg/mL smooth, highly cohesive, viscous hyaluronic acid filler and its role in facial rejuvenation therapy. Dermatol Surg (2010) 0.77
Adjunctive botulinum toxin type A: fillers and light-based therapies. Int Ophthalmol Clin (2005) 0.77
Shrinking upper and lower eyelid skin with a novel radiofrequency tip. Dermatol Surg (2007) 0.77
Botulinum toxin type A: history and current cosmetic use in the upper face. Dis Mon (2002) 0.77
Botulinum treatment of forehead wrinkles. Plast Reconstr Surg (2006) 0.77
A Randomized, Blinded Study to Validate the Merz Hand Grading Scale for Use in Live Assessments. Dermatol Surg (2015) 0.77
Introduction to Fillers. Plast Reconstr Surg (2015) 0.77
Photodynamic Therapy: A Clinical Consensus Guide. Dermatol Surg (2016) 0.77
Injecting botulinum toxin at different depths is not effective for the correction of eyebrow asymmetry. Dermatol Surg (2015) 0.77
Botulinum toxin: expanding role in medicine. Plast Reconstr Surg (2003) 0.76
A review of onabotulinumtoxinA (Botox). Aesthet Surg J (2013) 0.76
Hyaluronic acid gel in skin rejuvenation. J Drugs Dermatol (2007) 0.76
The evolution of botulinum neurotoxin type A for cosmetic applications. J Cosmet Laser Ther (2007) 0.76